Trial Search Results

A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell Lymphoma With MYC and/or BCL2 and/or BCL6

The main purpose of this study is to test the safety of RO6870810 given in combination with venetoclax (with or without rituximab) at different dose levels and to find out what effects, good or bad, the study drugs have on you.

Stanford is currently accepting patients for this trial.

Stanford Investigator(s):

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Chaitasi Majmudar
650-736-0959
Recruiting